EBV plus Diffuse Large B-Cell Lymphoma, NOS Shows Over-Expression of PD-L1/PD-1

被引：0
作者：
Jagannathan, Geetha [1 ]
Gong, Jerald [1 ]
Uppal, Guldeep [1 ]
机构：
[1] Thomas Jefferson Med Coll, Philadelphia, PA USA
来源：
LABORATORY INVESTIGATION | 2018年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1475
引用
收藏
页码：525 / 525
页数：1
相关论文
共 50 条
  • [21] Vincristine upregulates PD-L1 and increases the efficacy of PD-L1 blockade therapy in diffuse large B-cell lymphoma
    Ting Wei
    Manjun Li
    Zhigang Zhu
    Huabao Xiong
    Han Shen
    Hui Zhang
    Qinghua Du
    Qingshan Li
    Journal of Cancer Research and Clinical Oncology, 2021, 147 : 691 - 701
  • [22] EBV-positive diffuse large B-cell lymphoma features PD-L1 protein but not mRNA overexpression
    Xue, Tian
    Wang, Wei-Ge
    Zhou, Xiao-Yan
    Li, Xiao-Qiu
    PATHOLOGY, 2018, 50 (07) : 725 - 729
  • [23] Soluble PD-1 but Not PD-L1 Levels Predict Poor Outcome in Patients with High-Risk Diffuse Large B-Cell Lymphoma
    Vajavaara, Heli
    Mortensen, Julie Bondgaard
    Leivonen, Suvi-Katri
    Hansen, Ida Monrad
    Ludvigsen, Maja
    Holte, Harald
    Jorgensen, Judit
    Bjerre, Mette
    d'Amore, Francesco
    Leppa, Sirpa
    CANCERS, 2021, 13 (03) : 1 - 12
  • [24] PD-L1 expression and composition of tumor microenvironment in primary cutaneous diffuse large B-cell lymphoma
    Mitteldorf, C.
    Berisha, A.
    Tronnier, M.
    Pfaltz, M.
    Broekaert, S.
    Kerl, K.
    Mertz, K.
    Kempf, W.
    EXPERIMENTAL DERMATOLOGY, 2017, 26 (03) : E81 - E81
  • [25] Prognostic impact of PD-L1 expression in primary gastric and intestinal diffuse large B-cell lymphoma
    Eri Ishikawa
    Masanao Nakamura
    Kazuyuki Shimada
    Tsutomu Tanaka
    Akira Satou
    Kei Kohno
    Ayako Sakakibara
    Kazuhiro Furukawa
    Takeshi Yamamura
    Ryoji Miyahara
    Shigeo Nakamura
    Seiichi Kato
    Mitsuhiro Fujishiro
    Journal of Gastroenterology, 2020, 55 : 39 - 50
  • [26] Prognostic impact of PD-L1 expression in primary gastric and intestinal diffuse large B-cell lymphoma
    Ishikawa, Eri
    Nakamura, Masanao
    Shimada, Kazuyuki
    Tanaka, Tsutomu
    Satou, Akira
    Kohno, Kei
    Sakakibara, Ayako
    Furukawa, Kazuhiro
    Yamamura, Takeshi
    Miyahara, Ryoji
    Nakamura, Shigeo
    Kato, Seiichi
    Fujishiro, Mitsuhiro
    JOURNAL OF GASTROENTEROLOGY, 2020, 55 (01) : 39 - 50
  • [27] Utility of PD-1, PD-L1, and IDO-1 Stains in Ocular Extranodal Marginal Zone Lymphoma (MZL) and Diffuse Large B-cell Lymphoma (DLBCL)
    Craig, Alexander
    Gueney, Ekin
    Pekmezci, Melike
    Bloomer, Michele
    Laszik, Zoltan
    Ohgami, Robert S.
    Toland, Angus
    Vogel, Hannes
    Forns, Taylor
    Wang, Endi
    Rubenstein, James
    Wen, Kwun Wah
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2024, 32 (08) : 395 - 399
  • [28] Clinical significance of PD-1 and PD-L1 molecules in patients with diffuse large B-cell lymphoma, not otherwise specified: Correlation with clinical and pathological findings
    Karakatsanis, Stamatis
    Papadatos, Stamatis S.
    Syrigos, Nikolaos
    Marinos, Leonidas
    Pouliou, Evi
    Papanikolaou, Asimina
    JOURNAL OF BUON, 2021, 26 (02): : 569 - 579
  • [29] The Clinical and Biological Effects of PD-1 Expression on Tumor Cells in Diffuse Large B-Cell Lymphoma
    Hanamura, Ichiro
    Suzuki, Susumu
    Ota, Akinobu
    Murakami, Satsuki
    Satou, Akira
    Takahara, Taishi
    Karnan, Sivasundaram
    Lam, Vu Quang
    Nakamura, Ayano
    Takasugi, Souichi
    Yoshikawa, Kazuhiro
    Banno, Shogo
    Ejiri, Masayuki
    Tsuzuki, Toyonori
    Hosokawa, Yoshitaka
    Ueda, Ryuzo
    Takami, Akiyoshi
    HEMATO, 2021, 2 (02): : 368 - 382
  • [30] PD-L1/PD-1 pathway activation in EBV plus and MSI gastric cancers
    De Rosa, S.
    Libera, L.
    Magnoli, F.
    Capella, C.
    Sessa, F.
    Chiaravalli, A. M.
    VIRCHOWS ARCHIV, 2016, 469 : S169 - S169
12345